Tuesday, August 14, 2012

Theralase to Be Featured on “The Next Biggest Winner” Business TV Series


Toronto, Ontario – August 14, 2012, Theralase Technologies Inc. (TSX-V: TLT) announced today that it is will be featured on “The Next Biggest Winner”, a television series devoted to discovering undervalued companies with the ability to grow significantly in shareholder value and become a big winner as an investment opportunity.
The TV show, "The Next Biggest Winner," which showcases companies with significant growth potential is scheduled to air its in-depth interview with Roger Dumoulin-White, President and CEO of Theralase Technologies Inc. on the iChannel, Tuesday, August 14th at 7:30pm. The iChannel has over 1.3 million affluent Canadian subscribers who look to its business programming for new investment opportunities. For an advance preview, please visit http://www.thenextbiggestwinner.com/theralase-technologies-inc/ .
Roger Dumoulin-White, President and CEO of Theralase stated, “Being recognized by “The Next Biggest Winner” underscores the unlocked value and growth potential of Theralase in the near term. The Company has made impressive strides in the development of both our therapeutic laser therapy medical device business and our cancer therapy business.” Mr. Dumoulin-White went on to say that “Investor, shareholder and customer communication is one of our key mandates for the second half of 2012. In addition to our news releases, Theralase will publish a quarterly newsletter and has created active social media pages on Twitter, Facebook, LinkedIn and communicate weekly via a Theralase Blog.” Please visit www.Twitter.com/theralase, www.Facebook.com/theralase, www.LinkedIn.com/theralase and www.Blogspot.com/theralase to review these sites.
To our investors, shareholders, customers and friends of Theralase our 2011 Annual Report is online at our corporate website at http://www.theralase.com/documents/theralase_2011_annual_report_2011.pdf  and is filed on SEDAR.
About Theralase Technologies Inc.
Theralase Technologies Inc., founded in 1995, designs, develops, manufactures and markets patented, superpulsed laser technology utilized in biostimulation and biodestruction applications. Theralase technology is safe and effective in treating pain, inflammation and for tissue regeneration of neural muscular skeletal conditions and tissue healing in both humans and animals. Theralase develops patented Photo Dynamic Compound (PDC) technology focused at targeting and destroying cancers, bacteria and viruses when light activated by Theralase’s proprietary and patented laser technologies.

For further information please visit www.theralase.com , regulatory filings may be viewed by visiting www.sedar.com.
This press release contains forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation to update these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.
For More Information
Roger Dumoulin-White                                                                                   
President & CEO,                       
416-447-8455 ext. 225                                          
rwhite@theralase.com            

Greg Bewsh
Director of Investor Relations,
416-447-8455 ext. 262

No comments:

Post a Comment